首页> 外文会议>Annual International Conference of the IEEE Engineering in Medicine and Biology Society >Effects of optimized heart failure medication on central sleep apnea with Cheyne-Stokes respiration pattern in chronic heart failure with reduced left-ventricular ejection fraction
【24h】

Effects of optimized heart failure medication on central sleep apnea with Cheyne-Stokes respiration pattern in chronic heart failure with reduced left-ventricular ejection fraction

机译:优化的心力衰竭药物对慢性心力衰竭左心室射血分数降低的Cheyne-Stokes呼吸模式对中枢性睡眠呼吸暂停的影响

获取原文

摘要

Central Sleep Apnea with Cheyne Stokes Respiration (CSA-CSR) is often diagnosed in patients with chronic heart failure (CHF). CSA-CSR displays a periodic breathing pattern with a typical waxing and waning breathing with central sleep apnea phases in between. Optimization of heart failure medication with Angiotensin receptor neprilysin inhibition (ARNi) can effect phenotypic traits of CSA-CSR indicating improvements of both, hemodynamic parameters and central chemosensitivity.
机译:慢性心力衰竭(CHF)患者通常被诊断为伴有Cheyne Stokes呼吸的中枢性睡眠呼吸暂停(CSA-CSR)。 CSA-CSR表现出周期性的呼吸模式,典型的呼吸呈蜡状和减弱状态,中间出现中枢性睡眠呼吸暂停阶段。使用血管紧张素受体中性溶酶抑制素(ARNi)来优化心力衰竭药物可以影响CSA-CSR的表型特征,表明血液动力学参数和中枢化学敏感性均得到改善。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号